Juha O. Rinne

11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

Juha O. Rinne, David J. Brooks, Martin N. Rossor et al. · The Lancet Neurology · 2010 · 694 citations

Neurodegenerative Diseases, Ascending-dose Study, Alzheimer's Disease +10

The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers

Tiina Pohjalainen, Juha O. Rinne, Kjell Någren et al. · Molecular Psychiatry · 1998 · 674 citations

Functional Selectivity, Healthy Volunteers, Genetics +5

Parkinsonism, premature menopause, and mitochondrial DNA polymerase γ mutations: clinical and molecular genetic study

Petri Luoma, Atle Melberg, Juha O. Rinne et al. · The Lancet · 2004 · 540 citations

Neurodegenerative Diseases, Molecular Genetic Study, Genetic Disorder +12

Conversion of amyloid positive and negative MCI to AD over 3 years

Aren Okello, J. Koivunen, Paul Edison et al. · Neurology · 2009 · 513 citations · Full text

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography

Paul Edison, Christopher C. Rowe, Juha O. Rinne et al. · Journal of Neurology Neurosurgery & Psychiatry · 2008 · 427 citations